Cargando…
P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192143/ http://dx.doi.org/10.1016/S1569-1993(21)01110-3 |
_version_ | 1783705995803885568 |
---|---|
author | McClenaghan, E. Cosgriff, R. Brownlee, K. Ahern, S. Burgel, P.-R. Byrnes, C.A. Colombo, C. Corvol, H. Cheng, S.Y. Daneau, G. Elbert, A. Faro, A. Goss, C.H. Gulmans, V. Gutierrez, H. de Monestrol, I. Jung, A. Nährlich, L. Kashirskaya, N. Marshall, B.C. McKone, E. Middleton, P.G. Mondejar-Lopez, P. Pastor-Vivero, M.D. Padoan, R. Rizvi, S. Ruseckaite, R. Salvatore, M. Stephenson, A.L. da Silva Filho, L.V.R. Melo, J. Zampoli, M. Abdrakhmanov, O. Harutyunyan, S. Carr, S.B. |
author_facet | McClenaghan, E. Cosgriff, R. Brownlee, K. Ahern, S. Burgel, P.-R. Byrnes, C.A. Colombo, C. Corvol, H. Cheng, S.Y. Daneau, G. Elbert, A. Faro, A. Goss, C.H. Gulmans, V. Gutierrez, H. de Monestrol, I. Jung, A. Nährlich, L. Kashirskaya, N. Marshall, B.C. McKone, E. Middleton, P.G. Mondejar-Lopez, P. Pastor-Vivero, M.D. Padoan, R. Rizvi, S. Ruseckaite, R. Salvatore, M. Stephenson, A.L. da Silva Filho, L.V.R. Melo, J. Zampoli, M. Abdrakhmanov, O. Harutyunyan, S. Carr, S.B. |
author_sort | McClenaghan, E. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8192143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Cystic Fibrosis Society. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81921432021-06-11 P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study McClenaghan, E. Cosgriff, R. Brownlee, K. Ahern, S. Burgel, P.-R. Byrnes, C.A. Colombo, C. Corvol, H. Cheng, S.Y. Daneau, G. Elbert, A. Faro, A. Goss, C.H. Gulmans, V. Gutierrez, H. de Monestrol, I. Jung, A. Nährlich, L. Kashirskaya, N. Marshall, B.C. McKone, E. Middleton, P.G. Mondejar-Lopez, P. Pastor-Vivero, M.D. Padoan, R. Rizvi, S. Ruseckaite, R. Salvatore, M. Stephenson, A.L. da Silva Filho, L.V.R. Melo, J. Zampoli, M. Abdrakhmanov, O. Harutyunyan, S. Carr, S.B. J Cyst Fibros Posters European Cystic Fibrosis Society. 2021 2021-06-11 /pmc/articles/PMC8192143/ http://dx.doi.org/10.1016/S1569-1993(21)01110-3 Text en Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Posters McClenaghan, E. Cosgriff, R. Brownlee, K. Ahern, S. Burgel, P.-R. Byrnes, C.A. Colombo, C. Corvol, H. Cheng, S.Y. Daneau, G. Elbert, A. Faro, A. Goss, C.H. Gulmans, V. Gutierrez, H. de Monestrol, I. Jung, A. Nährlich, L. Kashirskaya, N. Marshall, B.C. McKone, E. Middleton, P.G. Mondejar-Lopez, P. Pastor-Vivero, M.D. Padoan, R. Rizvi, S. Ruseckaite, R. Salvatore, M. Stephenson, A.L. da Silva Filho, L.V.R. Melo, J. Zampoli, M. Abdrakhmanov, O. Harutyunyan, S. Carr, S.B. P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study |
title | P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study |
title_full | P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study |
title_fullStr | P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study |
title_full_unstemmed | P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study |
title_short | P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study |
title_sort | p083 clinical progression of sars-cov-2 infection in people with cystic fibrosis: a global observational study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192143/ http://dx.doi.org/10.1016/S1569-1993(21)01110-3 |
work_keys_str_mv | AT mcclenaghane p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT cosgriffr p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT brownleek p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT aherns p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT burgelpr p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT byrnesca p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT colomboc p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT corvolh p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT chengsy p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT daneaug p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT elberta p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT faroa p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT gossch p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT gulmansv p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT gutierrezh p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT demonestroli p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT junga p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT nahrlichl p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT kashirskayan p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT marshallbc p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT mckonee p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT middletonpg p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT mondejarlopezp p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT pastorviveromd p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT padoanr p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT rizvis p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT ruseckaiter p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT salvatorem p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT stephensonal p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT dasilvafilholvr p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT meloj p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT zampolim p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT abdrakhmanovo p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT harutyunyans p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT carrsb p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy AT p083clinicalprogressionofsarscov2infectioninpeoplewithcysticfibrosisaglobalobservationalstudy |